This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Pieris Pharmaceuticals Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Eva-Maria Hansbauer: Innovator in Fusion Proteins
Introduction
Eva-Maria Hansbauer is a prominent inventor based in Freising, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of novel fusion proteins.
Latest Patents
Hansbauer holds a patent for "Novel Fusion Proteins Specific for CD137 and GPC3." This innovative work showcases her expertise in creating targeted therapies that could have substantial implications in medical treatments.
Career Highlights
Currently, Eva-Maria Hansbauer is associated with Pieris Pharmaceuticals GmbH, where she continues to advance her research and development efforts. Her work at Pieris Pharmaceuticals focuses on innovative therapeutic solutions that address unmet medical needs.
Collaborations
Some of her notable coworkers include Rachida Siham Bel Aiba and Birgit Bossenmaier, who collaborate with her on various projects within the company.
Conclusion
Eva-Maria Hansbauer's contributions to the field of biotechnology, particularly through her patent on fusion proteins, highlight her role as an influential inventor. Her ongoing work at Pieris Pharmaceuticals continues to pave the way for advancements in targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile